Report #2869855

Overview

Sex

Female

Age

Age unknown

State

—

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (2)

Symptom narrative

Respiratory problems; Can not breathe good; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of respiratory disorder in a female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced respiratory disorder (Verbatim: Respiratory problems) and difficulty breathing (Verbatim: Can not breathe good). The outcome of the respiratory disorder and difficulty breathing were not reported. It was unknown if the reporter considered the respiratory disorder and difficulty breathing to be related to Arexvy. It was unknown if the company considered the respiratory disorder and difficulty breathing to be related to Arexvy. Additional Information: GSK Receipt Date: 19-OCT-2025 The reporter reported that the after receiving RSV shots had respiratory problems and could not breathe good. The reporter was telling the truth. The batch number was not provided and we and unable to contact the reporter.